Checkpoint Trends Limited (CHECKPOINT.BO)
INR 13.85
(-1.98%)
INR 13.85
(-1.98%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 297.07 Thousand INR | 138.23% |
| 2022 | -777.01 Thousand INR | -277.78% |
| 2021 | -205.67 Thousand INR | -305.77% |
| 2020 | 99.95 Thousand INR | -46.26% |
| 2019 | 185.99 Thousand INR | 110.24% |
| 2018 | -1.81 Million INR | -245.48% |
| 2017 | 1.24 Million INR | 263.07% |
| 2016 | 343.96 Thousand INR | 79721.76% |
| 2015 | -432.00 INR | 100.0% |
| 2014 | - INR | -31772.83% |
| 2013 | - INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 265.5 Thousand INR | 111.22% |
| 2023 Q3 | 577.25 Thousand INR | -77.78% |
| 2023 Q2 | 2.59 Million INR | 587.56% |
| 2023 FY | - INR | 138.09% |
| 2023 Q1 | -532.75 Thousand INR | 52.72% |
| 2023 Q4 | -2.36 Million INR | -510.13% |
| 2022 Q2 | 97 Thousand INR | -57.08% |
| 2022 Q3 | 16.99 Thousand INR | -82.48% |
| 2022 Q1 | 226 Thousand INR | 318.04% |
| 2022 FY | - INR | -277.78% |
| 2022 Q4 | -1.12 Million INR | -6731.24% |
| 2021 Q2 | 206 Thousand INR | 114.58% |
| 2021 Q3 | -404 Thousand INR | -296.12% |
| 2021 Q4 | -103.65 Thousand INR | 74.34% |
| 2021 Q1 | 96 Thousand INR | 28.06% |
| 2021 FY | - INR | -305.77% |
| 2020 Q4 | 74.96 Thousand INR | 393.06% |
| 2020 FY | - INR | -46.26% |
| 2020 Q1 | -55.75 Thousand INR | 74.14% |
| 2020 Q2 | 66 Thousand INR | 218.39% |
| 2020 Q3 | 15.2 Thousand INR | -76.96% |
| 2019 Q1 | 124.9 Thousand INR | 131.98% |
| 2019 FY | - INR | 110.24% |
| 2019 Q4 | -215.61 Thousand INR | -215.98% |
| 2019 Q2 | 80.9 Thousand INR | -35.23% |
| 2019 Q3 | 185.9 Thousand INR | 129.78% |
| 2018 Q3 | -727.14 Thousand INR | -46.56% |
| 2018 Q1 | -349.64 Thousand INR | -125.91% |
| 2018 Q2 | -496.14 Thousand INR | -41.9% |
| 2018 FY | - INR | -245.48% |
| 2018 Q4 | -390.54 Thousand INR | 46.29% |
| 2017 Q4 | 1.34 Million INR | 247.89% |
| 2017 Q3 | -912.32 Thousand INR | -400.43% |
| 2017 Q1 | 507.67 Thousand INR | 276.18% |
| 2017 Q2 | 303.67 Thousand INR | -40.18% |
| 2017 FY | - INR | 263.07% |
| 2016 Q3 | 105 Thousand INR | 0.96% |
| 2016 Q4 | 134.95 Thousand INR | 28.53% |
| 2016 FY | - INR | 79721.76% |
| 2016 Q1 | - INR | 100.0% |
| 2016 Q2 | 104 Thousand INR | 0.0% |
| 2015 Q3 | - INR | 0.0% |
| 2015 FY | - INR | 100.0% |
| 2015 Q2 | - INR | 0.0% |
| 2015 Q4 | -432.00 INR | 0.0% |
| 2015 Q1 | - INR | 100.0% |
| 2014 Q2 | - INR | 0.0% |
| 2014 FY | - INR | -31772.83% |
| 2014 Q1 | - INR | 100.0% |
| 2014 Q3 | - INR | 0.0% |
| 2014 Q4 | -30 Million INR | 0.0% |
| 2013 Q4 | -94.12 Thousand INR | 0.0% |
| 2013 FY | - INR | 0.0% |
| 2013 Q2 | - INR | 0.0% |
| 2013 Q3 | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 36.55 Million INR | 99.187% |
| Everest Organics Limited | 118.72 Million INR | 99.75% |
| GUJARAT INJECT (KERALA) LTD. | 1.05 Million INR | 71.778% |
| NATURO INDIABULL LIMITED | 14.68 Million INR | 97.977% |
| NEXUS SURGICAL AND MEDICARE LI | 2.98 Million INR | 90.038% |
| Rajnish Wellness Limited | 19.93 Million INR | 98.51% |
| Rama Vision Limited | 67.79 Million INR | 99.562% |
| Vivo Bio Tech Limited | 212.99 Million INR | 99.861% |